April 4 (Reuters) - Diamyd Medical AB DMYDb.ST :
* DIAMYD MEDICAL PARTNERS WITH JDRF TO ADVANCE THE
DIAGNODE-3
PHASE 3 TRIAL IN TYPE 1 DIABETES
* CO, JDRF HAVE ENTERED INTO FOUR-YEAR RESEARCH AND
DEVELOPMENT
COLLABORATION
* COLLABORATION INCLUDES NON-DILUTIVE $5 MILLION AWARD TO
DIAMYD
MEDICAL TO SUPPORT ITS ONGOING PHASE 3 TRIAL WITH PRECISION
MEDICINE ANTIGEN-SPECIFIC IMMUNOTHERAPY DIAMYD
* GRANT WILL BE FUNDED UNDER JDRF'S INDUSTRY DISCOVERY &
DEVELOPMENT PARTNERSHIPS PROGRAM
Source text for Eikon: ID:nWkr9ChgXg
Further company coverage: DMYDb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))